Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridrich

Showing results (251-260 of 286) with videos related to

Pageof 29
Sort By:
Theranostics|September 28, 2022
Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases preventionYana Epshtein, Rachel Blau, Evgeni Pisarevsky, et al.
Intensive & Critical Care Nursing|December 20, 2021
Nurse-performed ultrasound assessment of gastric residual volume and enteral nasogastric tube placement in the general intensive care unitEvgeni Brotfain, Alexander Erblat, Peter Luft, et al.
Journal of the American College of Cardiology|August 15, 2009
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysisMichelle O'Donoghue, Elliott M Antman, Eugene Braunwald, et al.
Proceedings. Biological Sciences|February 24, 2021
Conservation and turnover of miRNAs and their highly complementary targets in early branching animalsDaniela Praher, Bob Zimmermann, Rohit Dnyansagar, et al.
Molecular Pharmaceutics|August 6, 2011
Lipopolyplex ternary delivery systems incorporating C14 glycerol-based lipidsLaila Kudsiova, Barbara Fridrich, Jimmy Ho, et al.
Circulation|June 16, 2010
Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trialPh Gabriel Steg, Arthur Kerner, G B John Mancini, et al.
Scientific Reports|January 26, 2019
Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinasesKonstantin Karmilin, Carlo Schmitz, Michael Kuske, et al.
Molecular Metabolism|December 12, 2013
Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosisMelanie Kahle, Marion Horsch, Barbara Fridrich, et al.
Circulation|February 4, 2009
Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP)Eric J Rashba, Gervasio A Lamas, Jean-Philippe Couderc, et al.
Advanced Therapeutics|June 27, 2022
Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in MelanomaEvgeni Pisarevsky, Rachel Blau, Yana Epshtein, et al.
Pageof 29

Showing results (251-260 of 286) with videos related to

Sort By:
Pageof 29
Theranostics|September 28, 2022
Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases preventionYana Epshtein, Rachel Blau, Evgeni Pisarevsky, et al.
Intensive & Critical Care Nursing|December 20, 2021
Nurse-performed ultrasound assessment of gastric residual volume and enteral nasogastric tube placement in the general intensive care unitEvgeni Brotfain, Alexander Erblat, Peter Luft, et al.
Journal of the American College of Cardiology|August 15, 2009
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysisMichelle O'Donoghue, Elliott M Antman, Eugene Braunwald, et al.
Proceedings. Biological Sciences|February 24, 2021
Conservation and turnover of miRNAs and their highly complementary targets in early branching animalsDaniela Praher, Bob Zimmermann, Rohit Dnyansagar, et al.
Molecular Pharmaceutics|August 6, 2011
Lipopolyplex ternary delivery systems incorporating C14 glycerol-based lipidsLaila Kudsiova, Barbara Fridrich, Jimmy Ho, et al.
Circulation|June 16, 2010
Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trialPh Gabriel Steg, Arthur Kerner, G B John Mancini, et al.
Scientific Reports|January 26, 2019
Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinasesKonstantin Karmilin, Carlo Schmitz, Michael Kuske, et al.
Molecular Metabolism|December 12, 2013
Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosisMelanie Kahle, Marion Horsch, Barbara Fridrich, et al.
Circulation|February 4, 2009
Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP)Eric J Rashba, Gervasio A Lamas, Jean-Philippe Couderc, et al.
Advanced Therapeutics|June 27, 2022
Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in MelanomaEvgeni Pisarevsky, Rachel Blau, Yana Epshtein, et al.
Pageof 29